About this trial
ITARECIPE is a multicenter national registry designed to study the diagnosis and evolution of Chronic Pancreatitis
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age >/= 12 years;
Diagnosis "definite" or "probable" according to the "M-ANNHEIM" criteria;
First evidence of diagnosis within 12 months of enrolment.
Disqualifiers
Age < 12 years;
History of known disease with certainty for > 12 months.
Trial population
All patients with: * a new suspected (both clinical and/or diagnostic evaluation, indicating a suspected diagnosis according to standard criteria) * established diagnosis of Chronic Pancreatitis and willing to provide their clinical and anamnestic information.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Disease Progression
The collection of data on disease progression in terms of the need for medical, endoscopic or surgical therapy, the risk of pancreatic exo-endocrine failure and the risk of developing pancreatic and extrapancreatic complications and death.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.